Yahata, T., Mizoguchi, M., Kimura, A., Orimo, T., Toujima, S., Kuninaka, Y., . . . Ino, K. (2019). Programmed cell death ligand 1 disruption by clustered regularly interspaced short palindromic repeats/Cas9‐genome editing promotes antitumor immunity and suppresses ovarian cancer progression. Cancer Sci.
Styl ChicagoYahata, Tamaki, et al. "Programmed Cell Death Ligand 1 Disruption By Clustered Regularly Interspaced Short Palindromic Repeats/Cas9‐genome Editing Promotes Antitumor Immunity and Suppresses Ovarian Cancer Progression." Cancer Sci 2019.
Citace podle MLAYahata, Tamaki, et al. "Programmed Cell Death Ligand 1 Disruption By Clustered Regularly Interspaced Short Palindromic Repeats/Cas9‐genome Editing Promotes Antitumor Immunity and Suppresses Ovarian Cancer Progression." Cancer Sci 2019.